PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFenamole
Fenamole
Fenamole is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
0.025% capsaicin pain relief patchC2002632025-03-05
0.025% capsaicin patch (2 patches/pouch) 3% menthol plus 0.083% capsaicin pain relief patch (2 patches/pouch) 5% menthol pain relief patch (1 lar...C2002632024-08-15
0.025% capsaicin patch 4% lidocaine pain relief patch 4% lidocaine plus 1% menthol pain relief patch 5% menthol pain relief patchC2002632024-06-13
10% methyl salicylate pain relief patchC2002632024-06-27
2-count heat patchesC2002632024-12-19
4% lidocaine pain relief patchC2002632025-03-05
4% lidocaine plus 1% menthol pain relief patchC2002632025-03-05
5% menthol pain relief patchC2002632025-03-05
absorbine jr back patchC2002632024-09-25
absorbine jr. pain relieving knee patchC2002632024-09-25
Show 481 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
217 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DepressionD003863—F33.921—136
Skin diseasesD012871—L00-L99———123
InfectionsD007239EFO_0000544————112
Communicable diseasesD003141—————112
Atopic dermatitisD003876EFO_0000274L20———112
EczemaD004485—L30.9———112
DermatitisD003872—L30.9———112
AnhedoniaD059445—R45.84———112
MelanomaD008545—————112
ClubfootD003025—Q66.0———1—1
Show 7 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.9—11—68
Heart failureD006333EFO_0003144I50——1—45
BurnsD002056—T30.0—11—45
Acute painD059787—R52—11—34
Procedural painD000073818———11—34
Multiple myelomaD009101—C90.0211——3
Plasma cell neoplasmsD054219——111——2
Hemophagocytic lymphohistiocytosisD051359—D76.1——1——1
Lice infestationsD010373—B85.2——1——1
PediculusD010374————1——1
Show 2 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369—C8041——711
StrokeD020521EFO_0000712I63.9—1——78
PainD010146EFO_0003843R52—1——56
Diabetes mellitusD003920EFO_0000400E08-E13—1——45
Anxiety disordersD001008EFO_0006788F41.1—2——35
AtherosclerosisD050197EFO_0003914I25.1—1——34
HemorrhageD006470MP_0001914R58—1——34
Cerebral hemorrhageD002543———1——34
Cardiovascular diseasesD002318EFO_0000319I98—1——23
InflammationD007249MP_0001845——1——23
Show 36 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———1———23
Neoplasm metastasisD009362EFO_0009708—1———12
DeathD003643PATO_0001422—1———12
Disease progressionD018450——1————1
Treatment-resistant depressive disorderD061218——1————1
Autistic disorderD001321EFO_0003758F84.01————1
Autism spectrum disorderD000067877—F84.01————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Sleep apnea syndromesD012891EFO_0003877G47.3————1010
Obstructive sleep apneaD020181EFO_0003918G47.33————99
ApneaD001049—R06.81————88
HypertensionD006973EFO_0000537I10————77
Crohn diseaseD003424EFO_0000384K50————55
Inflammatory bowel diseasesD015212EFO_0003767—————55
Breast neoplasmsD001943EFO_0003869C50————55
Atrial fibrillationD001281EFO_0000275I48.0————55
Peripheral arterial diseaseD058729EFO_0004265—————55
Peripheral vascular diseasesD016491EFO_0003875I73.9————55
Show 174 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameFenamole
INNfenamole
Description
Fenamole is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Nc1nnnn1-c1ccccc1
Identifiers
PDB—
CAS-ID5467-78-7
RxCUI—
ChEMBL IDCHEMBL2106224
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDK4H264PBQ7 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 51,432 documents
View more details
Safety
Black-box Warning
Black-box warning for: Diclovix m
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
313,155 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use